Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial (Q57826741)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial |
article |
Statements
Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group (English)
F D Goebel
J W Mannhalter
M M Eibl
P J Grob
V de Gruttola
P D Griffiths
V Erfle
M Kunschak